← FDA Drug Approvals (Drugs@FDA)

APREMILAST

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2023-10-16

Drug application

FDA Application #

ANDA211674

Application type

Abbreviated New Drug Application (Generic)

Brand name

APREMILAST

Generic name

Apremilast

Active ingredients

APREMILAST

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

GLENMARK PHARMS LTD

First approval

2023-10-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown